Skip to main content
[Preprint]. 2021 Oct 5:2021.10.04.463106. [Version 1] doi: 10.1101/2021.10.04.463106

Figure 6.

Figure 6.

SARS-CoV-2-S variants PP assays. Concentration-response curves of (a) calpeptin, (b) aloxistatin, (c) apilimod, (d) CAA-0225, (e) brigatinib, and (f) VBY-825 in PP entry assays with Wuhan-Hu-1, B.1.1.7, and B.1.351 spike variants.